Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels

International Journal of Cardiology

Volumn 101, Issue 2, 2005, Pages 213-217

  Noto, Davide ^a   Cefalu', Angelo Baldassare ^a   Barbagallo, Carlo Maria ^a   Pace, Antonio ^a   Rizzo, Manfredi ^a   Marino, Giuseppina ^a   Caldarella, Rosalia ^a   Castello, Antonio ^b   Pernice, Vincenzo ^c   Notarbartolo, Alberto ^a   Averna, Maurizio Rocco ^a,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b Buccheri La Ferla Hospital   (Italy)

^c Villa Maria Eleonora Hospital   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Acute myocardial infarction; Coronary artery disease; Cystatin C; Unstable angina

Indexed keywords

CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CST3 GENE; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CASE-CONTROL STUDIES; CHOLESTEROL; CYSTATINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; TIME FACTORS; TRIGLYCERIDES;

EID: 21044438895     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.03.018     Document Type: Article

References (22)

1. Libby P., Geng Y.J., Aikawa M., et al. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7(5):1996 (Oct.);330-335
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850
3. Newby A.C., Southgate K.M., Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res. Cardiol. 89(Suppl. 1):1994;59-70
4. Thompson R.W., Parks W.C. Role of matrix metalloproteinases in abdominal aortic aneurysm. Ann. N. Y. Acad. Sci. 800:1996;157-174
5. Carmeliet P., Moons L., Lijnen R., Baes M., et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:1997;439-444
6. Rao S.K., Reddy K.V., Cohen J.R. Role of serine proteases in aneurysm development. Ann. N. Y. Acad. Sci. 800:1996;131-137
7. Sukhova G.K., Shi G.-P., Simon D.I., et al. Expression of elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102:1998;576-583
8. Garnero P., Borel O., Byrjalsen I., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273:1998;32347-32352
9. Kafienah W., Bromme D., Buttle D.J., et al. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331:1998;727-732
10. Abrahamson M., Islam M.Q., Szpirer J., et al. The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20. Hum. Genet. 82:1989;223-226
11. Shimizu-Tokiwa A., Kobata M., Io H., et al. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron. 92(1):2002;224-226
12. Shi G.P., Sukhova G.K., Grubb A., et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 104(9):1999;1191-1197
13. The Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21:2000;1502-1513
14. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J. Am. Coll. Cardiol. 36(3):2000 (Sep.);970-1062
15. Noto D., Barbagallo C.M., Cefalu' A.B., et al. Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up. Thromb. Haemost. 87(2):2002 (Feb.);206-210
16. Uhlmann E.J., Hock K.G., Issitt C., et al. Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II system, and correlation with creatinine. Clin. Chem. 47(11):2001 (Nov.);2031-2033
17. Parks W.C. Who are the proteolytic culprits in vascular disease? J. Clin. Invest. 104(9):1999;1167-1168
18. Lindholt J.S., Erlandsen E.J., Henneberg E.W. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br. J. Surg. 88(11):2001;1472-1475
19. Pfohl M., Schreiber I., Liebich H.M., et al. Upregulation of cholesterol synthesis after acute myocardial infarction - is cholesterol a positive acute phase reactant? Atherosclerosis. 142(2):1999 (Feb.);389-393
20. Wattanasuwan N., Khan I.A., Gowda R.M., et al. Effect of acute myocardial infarction on cholesterol ratios. Chest. 120(4):2001 (Oct.);1196-1199
21. Benedikz E., Merz G.S., Schwenk V., et al. Cellular processing of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. Amyloid. 6:1999;172-182
22. Bjarnadottir M., Wulff B.S., Sameni M., et al. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. Mol. Pathol. 51:1998;317-326